Abstract: The present invention relates to Gamma-amino butyric acid, optionally in combination with a Positive Allosteric Modulator of a GABA-receptor, for use in a method for preventing, or reducing risk of, hypoglycemia in a subject.

Abstract: Diabetes analysis system for analysis and interpretation of data related to glucose level (GL) in blood. The system includes an input module to receive GL related data from measurements of interstitial fluid in subcutaneous tissue, and a hypoglycemia identification module to identify hypoglycemic events by performing a computer-implemented automatic search of the received GL related data. All uninterrupted glucose levels less than a predetermined level in a same time series are considered as one hypoglycemic event. A hypoglycemia classification module analyzes, for each identified event, the glucose data during a predetermined first time period preceding the hypoglycemic event, to determine the glucose level during the first time period.